Full length articleNicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG (cas 121-24-4) ratios and reducing oxidative and inflammatory stress
-
Add time:09/10/2019 Source:sciencedirect.com
The disruption of redox state homeostasis, the overexpression of lipogenic transcription factors and enzymes, and the increase in lipogenic precursors induced by sweetened beverages are determinants of the development of nonalcoholic fatty liver disease.This study evaluated the action of nicotinamide (NAM) on the expression of glucose-6-phosphate dehydrogenase (G6PD) and redox, oxidative, and inflammatory states in a model of nonalcoholic hepatic steatosis induced by high and chronic consumption of carbohydrates. Male rats were provided drinking water with 30% glucose or fructose ad libitum for 12 weeks. Additionally, 30 days after the beginning of carbohydrate administration, some rats were simultaneously provided water with 0.06% or 0.12% NAM for 5 h daily over the next 8 weeks. Biochemical profiles and expression levels of G6PD, tumor necrosis factor α (TNFα), and NADPH oxidase 4 (NOX4) were evaluated together with glutathione/glutathione disulfide (GSH/GSSG) and reduced nicotinamide adenine dinucleotide (phosphate)/nicotinamide adenine dinucleotide (phosphate) [NAD(P)H/NAD(P)] ratios and thiobarbituric acid reactive substances (TBARS). The results showed that hepatic steatosis induced by the chronic consumption of glucose or fructose was associated with body weight gain and increased levels of serum glucose, insulin, triacylglycerols, free fatty acids, transaminases, and TBARS. In the liver, the expression and activity of G6PD increased along with the GSSG, TBARS, and TG concentrations. These alterations were reduced by NAM treatment through the attenuation of increases in G6PD expression and activity and in the NADPH/NADP+ ratio, thereby slowing liver steatosis. NAM prevents redox, oxidative, and inflammatory alterations induced by high carbohydrate consumption.
We also recommend Trading Suppliers and Manufacturers of GSSG (cas 121-24-4). Pls Click Website Link as below: cas 121-24-4 suppliers
Prev:A sensitive and selective chemosensor for GSSG (cas 121-24-4) detection based on the recovered fluorescence of NDPA-Fe3O4@SiO2-Cu(II) nanomaterial
Next:Derivatization of GSSG (cas 121-24-4) by pHMB in alkaline media. Determination of oxidized glutathione in blood) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Increased efflux of oxidized glutathione (GSSG (cas 121-24-4)) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes09/26/2019
- Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG (cas 121-24-4)) in biological samples: An elephant in the room09/25/2019
- Derivatization of GSSG (cas 121-24-4) by pHMB in alkaline media. Determination of oxidized glutathione in blood09/24/2019
- A sensitive and selective chemosensor for GSSG (cas 121-24-4) detection based on the recovered fluorescence of NDPA-Fe3O4@SiO2-Cu(II) nanomaterial09/09/2019
- GSSG (cas 121-24-4)/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress09/08/2019
- ReviewThe fairytale of the GSSG (cas 121-24-4)/GSH redox potential☆09/07/2019
- Photoelectrochemical endocrine-disrupting chemicals aptasenor based on resonance energy transfer between SnSe/GR and AuNPs along with GSSG (cas 121-24-4) for signal amplification09/06/2019
- The GSH- and GSSG (cas 121-24-4)-bound structures of glutaredoxin from Clostridium oremlandii09/05/2019
- A standardized protocol for comparable analysis of GSH/GSSG (cas 121-24-4) by UHPLC-ESI-MSMS for human plasma09/04/2019


